title: Oncologic markers in patients with colorectal cancer after a complex therapy.
abstract: The authors present a prospective study on a value of oncologic markers CEA and CA 19-9 in patients after curative therapy for colorectal adenocarcinoma. During a five-year follow-up in 320 patients, a significant elevation of CEA or CA 19-9 was documented in 71 patients (22.8 %), and resulted in tumour detection in 39/71 patients (55 %). Although the levels were defined as false positive in 32 patients (45 %), the importance of CEA and CA 19-9 monitoring is documented by elevated levels of oncomakers in 39/55 patients (71%) with metastases or local-regional recurrence of colorectal adenocarcinoma. (Tab. 3, Ref: 21.)
authors.affiliation: 2nd Department of Surgery, University Hospital and Faculty of Medicine, Palacky University, Olomouc, Czech Republic. bll@fmed.uniba.sk
authors.forename: K
authors.initials: K
authors.lastname: Vyslouzil
authors.forename: I
authors.initials: I
authors.lastname: Klementa
authors.forename: L
authors.initials: L
authors.lastname: Stary
authors.forename: M
authors.initials: M
authors.lastname: Duda
authors.forename: P
authors.initials: P
authors.lastname: Skalicky
authors.forename: M
authors.initials: M
authors.lastname: Kapustova
authors.forename: M
authors.initials: M
authors.lastname: Dlouhy
authors.forename: P
authors.initials: P
authors.lastname: Benes
mesh_terms: D018395:CA-19-9 Antigen / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood*; D015179:Colorectal Neoplasms / Q000097:blood / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000556:secondary; D008175:Lung Neoplasms / Q000175:diagnosis / Q000556:secondary; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis
chemical_list: D018395:CA-19-9 Antigen; D002272:Carcinoembryonic Antigen